Related references
Note: Only part of the references are listed.Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM
Charles J. Vaske et al.
BIOINFORMATICS (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Value of Integrated Positron Emission Tomography Revised Using a Phantom Study to Evaluate Malignancy Grade of Lung Adenocarcinoma A Multicenter Study
Haruhiko Nakayama et al.
CANCER (2010)
Prioritization of driver mutations in pancreatic cancer using cancer-specific high-throughput annotation of somatic mutations (CHASM)
Hannah Carter et al.
CANCER BIOLOGY & THERAPY (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
BRCA1 CpG Island Hypermethylation Predicts Sensitivity to Poly(Adenosine Diphosphate)-Ribose Polymerase Inhibitors Reply
Timothy A. Yap et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
BRCA1 CpG Island Hypermethylation Predicts Sensitivity to Poly(Adenosine Diphosphate)-Ribose Polymerase Inhibitors
Jurgen Veeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
Ashour Ahmed Ahmed et al.
JOURNAL OF PATHOLOGY (2010)
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim et al.
NATURE (2010)
Researchers find a new cancer gene and a possible link between ovarian cancer and endometriosis
[Anonymous]
WOMENS HEALTH (2010)
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Kimberly C. Wiegand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma
Kuan-Ting Kuo et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Cancer-Specific High-Throughput Annotation of Somatic Mutations: Computational Prediction of Driver Missense Mutations
Hannah Carter et al.
CANCER RESEARCH (2009)
Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas
Dariush Etemadmoghadam et al.
CLINICAL CANCER RESEARCH (2009)
Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors
Ana M. Mendes-Pereira et al.
EMBO MOLECULAR MEDICINE (2009)
Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology Group
David S. Miller et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
Michael A. Bookman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing
Andreas Gnirke et al.
NATURE BIOTECHNOLOGY (2009)
Hybrid selection of discrete genomic intervals on custom-designed microarrays for massively parallel sequencing
Emily Hodges et al.
NATURE PROTOCOLS (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
PID: the Pathway Interaction Database
Carl F. Schaefer et al.
NUCLEIC ACIDS RESEARCH (2009)
Human Protein Reference Database-2009 update
T. S. Keshava Prasad et al.
NUCLEIC ACIDS RESEARCH (2009)
Pro-proliferative FoxM1 is a target of p53-mediated repression
A. M. Barsotti et al.
ONCOGENE (2009)
Deletion of Forkhead Box M1 Transcription Factor from Respiratory Epithelial Cells Inhibits Pulmonary Tumorigenesis
I-Ching Wang et al.
PLOS ONE (2009)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion
Jung-Hye Choi et al.
CANCER RESEARCH (2008)
A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer
Tomas Bonome et al.
CANCER RESEARCH (2008)
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
Richard W. Tothill et al.
CLINICAL CANCER RESEARCH (2008)
Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma
Alicia A. Tone et al.
CLINICAL CANCER RESEARCH (2008)
Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis
Chad J. Creighton et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The cell of origin of ovarian epithelial tumours
Louis Dubeau
LANCET ONCOLOGY (2008)
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding et al.
NATURE (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma
Rameen Beroukhim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The emerging roles of forkhead box (Fox) proteins in cancer
Stephen S. Myatt et al.
NATURE REVIEWS CANCER (2007)
被撤回的出版物: An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer (Retracted article. See vol. 30, pg. 678, 2012)
Holly K. Dressman et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: A kin-cohort study in Ontario, Canada
Harvey A. Risch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Identification and characterization of the CDK12/cyclin L1 complex involved in alternative splicing regulation
HH Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases
T Pal et al.
CANCER (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers
KW Cheng et al.
NATURE MEDICINE (2004)
The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin
JD Seidman et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2004)
p53 mutation is infrequent in clear cell carcinoma of the ovary
ESC Ho et al.
GYNECOLOGIC ONCOLOGY (2001)
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors
M Esteller et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
